디티앤씨

187220KOSDAQ기타 과학기술 서비스업

62.3 / 100

Reference Date: 2026-07-24

Financial Score23.0 / 40

News Sentiment21.3 / 25

Momentum8.0 / 20

Disclosure10.0 / 15

AI Analysis: PBR is significantly undervalued vs. peers but ROE is below the industry average. Slightly up 3.6% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

DT&C is an engineering consulting company providing testing, inspection, and certification services for products in electronics, automotive, industrial, and biotechnology sectors. The company's main revenue comes from electronics and biotechnology sectors, with subsidiaries offering clinical trials for pharmaceuticals and financial services such as venture capital.

Number of Employees

306people

Average Salary

55.0M KRW

Score Calculation Basis

Detailed Financial Score

PER

13.20Industry Average 13.255.0Point

In line with industry avg

PBR

0.24Industry Average 1.357.0Point

Half of industry avg (excellent)

ROE

-0.67Industry Average -0.673.5Point

In line with industry avg

Debt Ratio

29.09Industry Average 25.422.0Point

Higher than industry avg (caution)

Trend 2023~20255.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲14.1% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲81.0% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -6.6% (improving, 3yr)

Detailed News Sentiment

1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 85

Positive
세이프소프트 "인공지능이 임상 데이터 관리 전주기 지원"
세이프소프트의 AI 기반 임상시험 데이터 관리 플랫폼 출시로 디티앤씨 바이오그룹의 기술 경쟁력 강화.

Detailed Momentum

52-week position3.0Point

52w lower range (20%)

Current 2,415Won52-week high 3,37552-week low 2,175

1-month return4.0Point

1m +3.65% (slight rise)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral주식등의대량보유상황보고서(약식)2026-07-10